Expression and influence of pentraxin-3, HbAlc and ApoA1/ApoB in serum of patients with acute myocardial infarction combined with diabetes mellitus type 2.
Increased Neutrophil elastase and proteinase 3 are closely associated with occurrence and severity of stroke and acute myocardial infarction in patients with type 2 diabetes mellitus.
[Venous thrombolysis with the recombinant human tissue-type plasminogen activator (rt-PA) during the first 3 hours following acute myocardial infarction. Controlled pilot study with placebo].
Digital Health Intervention in Acute Myocardial Infarction.
Marvel FA, Spaulding EM, Lee MA, Yang WE, Demo R, Ding J, Wang J, Xun H, Shah LM, Weng D, Carter J, Majmudar M, Elgin E, Sheidy J, McLin R, Flowers J, Vilarino V, Lumelsky DN, Bhardwaj V, Padula WV, Shan R, Huynh PP, Wongvibulsin S, Leung C, Allen JK, Martin SS.
Circ Cardiovasc Qual Outcomes. 2021 Jul;14(7):e007741. doi: 10.1161/CIRCOUTCOMES.121.007741. Epub 2021 Jul 15.
Defining and managing patients with non-ST-elevation myocardial infarction: Sorting through type 1 vs other types.
Cohen M, Visveswaran G.
Clin Cardiol. 2020 Mar;43(3):242-250. doi: 10.1002/clc.23308. Epub 2020 Jan 10.
Secretome Analysis of Cardiomyocytes Identifies PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6) as a Novel Player in Cardiac Remodeling After Myocardial Infarction.
Kuhn TC, Knobel J, Burkert-Rettenmaier S, Li X, Meyer IS, Jungmann A, Sicklinger F, Backs J, Lasitschka F, Müller OJ, Katus HA, Krijgsveld J, Leuschner F.
Circulation. 2020 May 19;141(20):1628-1644. doi: 10.1161/CIRCULATIONAHA.119.044914. Epub 2020 Feb 26.
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.
Keeley EC, Boura JA, Grines CL.
Lancet. 2003 Jan 4;361(9351):13-20. doi: 10.1016/S0140-6736(03)12113-7.
The Impact of Type of Acute Myocardial Infarction on Cardiac Patient Self-efficacy After Hospitalization.
Shajrawi AM, Al-Smadi AM, Ashour A, Momani A, Al-Akash HY, Granat M, Jones I.
Dimens Crit Care Nurs. 2022 Nov-Dec 01;41(6):295-304. doi: 10.1097/DCC.0000000000000547.
Timing of SGLT2i initiation after acute myocardial infarction.
von Lewinski D, Kolesnik E, Aziz F, Benedikt M, Tripolt NJ, Wallner M, Pferschy PN, von Lewinski F, Schwegel N, Holman RR, Oulhaj A, Moertl D, Siller-Matula J, Sourij H.
Cardiovasc Diabetol. 2023 Sep 30;22(1):269. doi: 10.1186/s12933-023-02000-5.
High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction.
Chapman AR, Adamson PD, Shah ASV, Anand A, Strachan FE, Ferry AV, Lee KK, Berry C, Findlay I, Cruikshank A, Reid A, Gray A, Collinson PO, Apple F, McAllister DA, Maguire D, Fox KAA, Vallejos CA, Keerie C, Weir CJ, Newby DE, Mills NL; High-STEACS Investigators.
Circulation. 2020 Jan 21;141(3):161-171. doi: 10.1161/CIRCULATIONAHA.119.042960. Epub 2019 Oct 7.
FSTL3 partially mediates the association of increased nonalcoholic fatty liver disease fibrosis risk with acute myocardial infarction in patients with type 2 diabetes mellitus.
Duan W, Shi R, Yang F, Zhou Z, Wang L, Huang Z, Zang S.
Cardiovasc Diabetol. 2023 Oct 30;22(1):297. doi: 10.1186/s12933-023-02024-x.
Acute Kidney Injury in Acute Myocardial Infarction and Its Outcome at 3 and 6 Months.
Kaur J, Bhardwaj N, Reddy S, D'Cruz S.
Saudi J Kidney Dis Transpl. 2023 Jul 1;34(4):297-304. doi: 10.4103/1319-2442.395445. Epub 2024 Feb 12.
Type 1, Type 2 Myocardial Infarction and Non-Ischemic Myocardial Injury-Opinion from the Front Lines.
Alpert JS, Jaffe AS, White HD, Thygesen KA.
Am J Med. 2022 Aug;135(8):935-938. doi: 10.1016/j.amjmed.2022.03.004. Epub 2022 Mar 25.
